Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update

Straumann Holding AG (OTCMKTS:SAUHY) was the target of a significant growth in short interest in January. As of January 15th, there was short interest totaling 58,271 shares, a growth of 334.8% from the December 31st total of 13,401 shares. Based on an average daily volume of 121,542 shares, the short-interest ratio is currently 0.5 days. Based on an average daily volume of 121,542 shares, the short-interest ratio is currently 0.5 days.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on SAUHY. Deutsche Bank Aktiengesellschaft upgraded Straumann from a “hold” rating to a “buy” rating in a research report on Friday, October 31st. Citigroup reaffirmed a “sell” rating on shares of Straumann in a research note on Wednesday, January 14th. UBS Group raised shares of Straumann from a “sell” rating to a “neutral” rating in a report on Tuesday, November 4th. The Goldman Sachs Group downgraded shares of Straumann from a “strong-buy” rating to a “neutral” rating in a research note on Monday, October 13th. Finally, Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Straumann Stock Up 2.0%

Shares of SAUHY stock opened at $12.57 on Wednesday. The firm’s 50-day moving average is $11.94 and its two-hundred day moving average is $11.91. Straumann has a 12 month low of $10.30 and a 12 month high of $15.00.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.